61 – 70 of 74
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2011
- 
                        Mark
        Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.
    
    - Contribution to journal › Article
 
- 2010
- 
                        Mark
        Increased sensitivity to neutralizing antibodies of end-stage disease R5 HIV-1 is concomitant with reduced gp120 glycosylation and increased plus charge
    
    - Contribution to journal › Published meeting abstract
 
- 
                        Mark
        Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections
    
    - Contribution to journal › Article
 
- 2009
- 
                        Mark
        Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group
    
    - Contribution to journal › Published meeting abstract
 
- 
                        Mark
        Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections
    
    - Contribution to journal › Article
 
- 
                        Mark
        Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
    
    - Contribution to journal › Published meeting abstract
 
- 
                        Mark
        Mode of Coreceptor Use by R5 HIV Type 1 Correlates with Disease Stage: A Study of Paired Plasma and Cerebrospinal Fluid Isolates.
    
    - Contribution to journal › Article
 
- 2008
- 
                        Mark
        Suppression of HIV replication in vitro by CpG and CpG conjugated to the non toxic B subunit of cholera toxin
    
    - Contribution to journal › Article
 
- 
                        Mark
        Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-I variants emerging during AIDS progression
    
    - Contribution to journal › Article
 
- 
                        Mark
        Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
    
    - Contribution to journal › Article
 
